CONTEXT: Reproductive function may improve after bariatric surgery, although the mechanisms and time-related changes are unclear. OBJECTIVE: The objective of the study was to determine whether ovulation frequency/quality as well as associated reproductive parameters improve after Roux en Y gastric bypass surgery. DESIGN: This was a prospective cohort study that enrolled female subjects from 2005 to 2008 with study visits at baseline and then 1, 3, 6, 12, and up to 24 months after surgery. SETTING: The study was conducted at an academic health center. PATIENTS: Twenty-nine obese, reproductive-aged women not using confounding medications participated in the study. MAIN OUTCOME MEASURES: The primary outcome was integrated levels of urinary progestin (pregnanediol 3-glururonide) from daily urinary collections at 12 months postoperatively. Secondary outcomes were changes in vaginal bleeding, other biometric, hormonal, ultrasound, dual-energy x-ray absorptiometry measures, and Female Sexual Function Index. RESULTS: Ninety percent of patients with morbid obesity had ovulatory cycles at baseline, and the ovulatory frequency and luteal phase quality (based on integrated pregnanediol 3-glururonide levels) were not modified by bariatric surgery. The follicular phase was shorter postoperatively [6.5 d shorter at 3 months and 7.9-8.9 d shorter at 6-24 months (P < 0.01)]. Biochemical hyperandrogenism improved, largely due to an immediate postoperative increase in serum SHBG levels (P < 0.01), with no change in clinical hyperandrogenism (sebum production, acne, hirsutism). Bone density was preserved, contrasting with a significant loss of lean muscle mass and fat (P < 0.001), reflecting preferential abdominal fat loss (P < 0.001). Female sexual function improved 28% (P = 0.02) by 12 months. CONCLUSIONS: Ovulation persists despite morbid obesity and the changes from bypass surgery. Reproductive function after surgery is characterized by a shortened follicular phase and improved female sexual function.
CONTEXT: Reproductive function may improve after bariatric surgery, although the mechanisms and time-related changes are unclear. OBJECTIVE: The objective of the study was to determine whether ovulation frequency/quality as well as associated reproductive parameters improve after Roux en Y gastric bypass surgery. DESIGN: This was a prospective cohort study that enrolled female subjects from 2005 to 2008 with study visits at baseline and then 1, 3, 6, 12, and up to 24 months after surgery. SETTING: The study was conducted at an academic health center. PATIENTS: Twenty-nine obese, reproductive-aged women not using confounding medications participated in the study. MAIN OUTCOME MEASURES: The primary outcome was integrated levels of urinary progestin (pregnanediol 3-glururonide) from daily urinary collections at 12 months postoperatively. Secondary outcomes were changes in vaginal bleeding, other biometric, hormonal, ultrasound, dual-energy x-ray absorptiometry measures, and Female Sexual Function Index. RESULTS: Ninety percent of patients with morbid obesity had ovulatory cycles at baseline, and the ovulatory frequency and luteal phase quality (based on integrated pregnanediol 3-glururonide levels) were not modified by bariatric surgery. The follicular phase was shorter postoperatively [6.5 d shorter at 3 months and 7.9-8.9 d shorter at 6-24 months (P < 0.01)]. Biochemical hyperandrogenism improved, largely due to an immediate postoperative increase in serum SHBG levels (P < 0.01), with no change in clinical hyperandrogenism (sebum production, acne, hirsutism). Bone density was preserved, contrasting with a significant loss of lean muscle mass and fat (P < 0.001), reflecting preferential abdominal fat loss (P < 0.001). Female sexual function improved 28% (P = 0.02) by 12 months. CONCLUSIONS: Ovulation persists despite morbid obesity and the changes from bypass surgery. Reproductive function after surgery is characterized by a shortened follicular phase and improved female sexual function.
Authors: Andrew S Rowland; Donna Day Baird; Stuart Long; Ganesa Wegienka; Siobán D Harlow; Michael Alavanja; Dale P Sandler Journal: Epidemiology Date: 2002-11 Impact factor: 4.822
Authors: N P Johnson; A W Stewart; J Falkiner; C M Farquhar; S Milsom; V-P Singh; Q L Okonkwo; K L Buckingham Journal: Hum Reprod Date: 2010-04-30 Impact factor: 6.918
Authors: I Kato; P Toniolo; K L Koenig; R E Shore; A Zeleniuch-Jacquotte; A Akhmedkhanov; E Riboli Journal: Eur J Epidemiol Date: 1999-10 Impact factor: 8.082
Authors: Robyn A Tamboli; H Ayesha Hossain; Pamela A Marks; Aaron W Eckhauser; John A Rathmacher; Sharon E Phillips; Maciej S Buchowski; Kong Y Chen; Naji N Abumrad Journal: Obesity (Silver Spring) Date: 2010-04-22 Impact factor: 5.002
Authors: Susan R Reutman; Grace Kawas LeMasters; James S Kesner; Rakesh Shukla; Edward F Krieg; Edwin A Knecht; James E Lockey Journal: Fertil Steril Date: 2002-08 Impact factor: 7.329
Authors: Nanette Santoro; Bill Lasley; Dan McConnell; Jenifer Allsworth; Sybil Crawford; Ellen B Gold; Joel S Finkelstein; Gail A Greendale; Jenny Kelsey; Stan Korenman; Judith L Luborsky; Karen Matthews; Rees Midgley; Lynda Powell; Janice Sabatine; Miriam Schocken; Mary Fran Sowers; Gerson Weiss Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro Journal: Endocr Rev Date: 2015-10 Impact factor: 19.871
Authors: Richard S Legro; Robert G Brzyski; Michael P Diamond; Christos Coutifaris; William D Schlaff; Ruben Alvero; Peter Casson; Gregory M Christman; Hao Huang; Qingshang Yan; Daniel J Haisenleder; Kurt T Barnhart; G Wright Bates; Rebecca Usadi; Richard Lucidi; Valerie Baker; J C Trussell; Stephen A Krawetz; Peter Snyder; Dana Ohl; Nanette Santoro; Esther Eisenberg; Heping Zhang Journal: Fertil Steril Date: 2013-10-21 Impact factor: 7.329
Authors: Richard S Legro; William C Dodson; Allen R Kunselman; Christy M Stetter; Penny M Kris-Etherton; Nancy I Williams; Carol L Gnatuk; Stephanie J Estes; Kelly C Allison; David B Sarwer; Michael P Diamond; William D Schlaff; Peter R Casson; Gregory M Christman; Kurt T Barnhart; G Wright Bates; Rebecca Usadi; Scott Lucidi; Valerie Baker; Heping Zhang; Esther Eisenberg; Christos Coutifaris; Anuja Dokras Journal: J Clin Endocrinol Metab Date: 2016-05-12 Impact factor: 5.958
Authors: Richard S Legro; Allen R Kunselman; Juliana W Meadows; James S Kesner; Edward F Krieg; Ann M Rogers; Robert N Cooney Journal: Reprod Biomed Online Date: 2014-11-05 Impact factor: 3.828
Authors: Lauren W Roth; Amanda A Allshouse; Erica L Bradshaw-Pierce; Jennifer Lesh; Justin Chosich; Wendy Kohrt; Andrew P Bradford; Alex J Polotsky; Nanette Santoro Journal: Clin Endocrinol (Oxf) Date: 2014-03-20 Impact factor: 3.478
Authors: David B Sarwer; Thomas A Wadden; Jacqueline C Spitzer; James E Mitchell; Kathy Lancaster; Anita Courcoulas; William Gourash; Raymond C Rosen; Nicholas J Christian Journal: Obes Surg Date: 2018-04 Impact factor: 4.129